About The Author

Satoshi Kubo is a researcher affiliated with the University of Occupational and Environmental Health, Japan in The First Department of Internal Medicine. Their research focuses primarily on the diagnosis and treatment of patients with rheumatoid arthritis.

TNF Inhibitors In Patients With Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic inflammatory disease that manifests clinically with polyarthritis and joint destruction. With the development of biologic agents targeting pro-inflammatory cytokines such as TNF, clinical remission has become a primary goal in the treatment of RA. Moreover, structural and functional remission has become possible. In addition to TNF inhibitors, the safety